Efficacy and Safety of Oral NEPA Versus Fosaprepitant Plus Palonosetron for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Nasopharyngeal Carcinoma: A Propensity-Score-Matched Retrospective Study.

Cancers (Basel) · 2026 · PMC13204631 · PMID 42192892

Europe PMC DOI

hedged sentence

0.0620

closest p · 1.2× alpha

0.0620

boldest claim

The sentences

a favorable trendp = 0.062so close (0.05 < p ≤ 0.1)

In the first IC cycle, the rates were 14.5% versus 22.0% ( p = 0.045), and in the first CCRT cycle, a favorable trend was observed (18.2% vs. 25.7%, p = 0.062).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.